Pathstone Family Office’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $32.2M | Buy |
62,932
+27,083
| +76% | +$13.3M | 0.25% | 69 |
|
|
2023
Q2 | $17.7M | Buy |
35,849
+152
| +0.4% | +$74.3K | 0.25% | 69 |
|
|
2023
Q1 | $17.3M | Sell |
35,697
-74,787
| -68% | -$36.1M | 0.28% | 62 |
|
|
2022
Q4 | $221M | Buy |
110,484
+26,784
| +32% | +$14.2M | 1.88% | 8 |
|
|
2022
Q3 | $43.3M | Buy |
83,700
+45,813
| +121% | +$24.1M | 0.39% | 45 |
|
|
2022
Q2 | $19.5M | Buy |
37,887
+17,565
| +86% | +$8.82M | 0.43% | 46 |
|
|
2022
Q1 | $10.9M | Sell |
20,322
-1,707
| -8% | -$823K | 0.25% | 50 |
|
|
2021
Q4 | $11.1M | Buy |
22,029
+1,043
| +5% | +$472K | 0.28% | 48 |
|
|
2021
Q3 | $8.2M | Buy |
20,986
+1,613
| +8% | +$668K | 0.24% | 50 |
|
|
2021
Q2 | $7.76M | Buy |
19,373
+649
| +3% | +$259K | 0.23% | 58 |
|
|
2021
Q1 | $6.97M | Buy |
18,724
+15,037
| +408% | +$5.21M | 0.24% | 58 |
|
|
2020
Q4 | $1.29M | Buy |
3,687
+3,368
| +1,056% | +$1.13M | 0.05% | 107 |
|
|
2020
Q3 | $100K | Sell |
319
-20
| -6% | -$6.14K | 0.01% | 284 |
|
|
2020
Q2 | $102K | Buy |
339
+15
| +5% | +$4.3K | 0.01% | 227 |
|
|
2020
Q1 | $82K | Buy |
324
+122
| +60% | +$33.6K | 0.01% | 246 |
|
|
2019
Q4 | $593K | Sell |
202
-2
| -1% | -$523 | 0.01% | 271 |
|
|
2019
Q3 | $42K | Buy |
204
+24
| +13% | +$5.79K | 0.01% | 298 |
|
|
2019
Q2 | $46K | Sell |
180
-524
| -74% | -$126K | 0.01% | 338 |
|
|
2019
Q1 | $176K | Buy |
704
+95
| +16% | +$24.2K | 0.02% | 180 |
|
|
2018
Q4 | $153K | Buy |
609
+12
| +2% | +$3.17K | 0.04% | 101 |
|
|
2018
Q3 | $160K | Buy |
597
+558
| +1,431% | +$145K | 0.05% | 63 |
|
|
2018
Q2 | $10K | Sell |
39
-627
| -94% | -$151K | 0.01% | 124 |
|
|
2018
Q1 | $142K | Buy |
666
+83
| +14% | +$19K | 0.08% | 58 |
|
|
2017
Q4 | $129K | Buy |
+583
| New | +$124K | 0.07% | 41 |
|
|
2017
Q3 | – | Sell |
-583
| Closed | -$108K | – | 328 |
|
|
2017
Q2 | $108K | Sell |
583
-23
| -4% | -$4.03K | 0.05% | 146 |
|
|
2017
Q1 | $100K | Buy |
+606
| New | +$99.2K | 0.06% | 132 |
|
|
2016
Q4 | – | Sell |
-583
| Closed | -$82K | – | 198 |
|
|
2016
Q3 | $82K | Buy |
+583
| New | +$81.7K | 0.08% | 45 |
|
|
2016
Q2 | – | Sell |
-583
| Closed | -$75K | – | 216 |
|
|
2016
Q1 | $75K | Buy |
+583
| New | +$69K | 0.15% | 39 |
|
|
2015
Q4 | – | Sell |
-583
| Closed | -$68K | – | 162 |
|
|
2015
Q3 | $68K | Buy |
+583
| New | +$69.8K | 0.18% | 30 |
|
|
2015
Q2 | – | Sell |
-583
| Closed | -$69K | – | 140 |
|
|
2015
Q1 | $69K | Buy |
+583
| New | +$64.7K | 0.11% | 33 |
|
|
2014
Q4 | – | Sell |
-375
| Closed | -$32K | – | 255 |
|
|
2014
Q3 | $32K | Buy |
+375
| New | +$31.7K | 0.1% | 76 |
|
Other funds holding UNH
Pathstone Family Office's UNH Position: Q3 2023 in Review
Pathstone Family Office increased its UnitedHealth (UNH) stake by 76% in Q3 2023, buying an estimated $13.3M and bringing the position to 62,932 shares worth $32.2M. The position accounts for 0.25% of the portfolio, ranked #69.
Pathstone Family Office first reported a position in UNH in Q3 2014 and has held it in 31 quarters since. The position peaked at $221M in Q4 2022. 3,137 funds tracked by Wall St. Rank hold UNH as of Q3 2023.
- Pathstone Family Office held 62,932 shares of UnitedHealth worth $32.2M as of Q3 2023.
- Pathstone Family Office bought 27,083 UnitedHealth shares in Q3 2023, an estimated $13.3M.
- UnitedHealth made up 0.25% of Pathstone Family Office's portfolio in Q3 2023, its #69 holding.
- Pathstone Family Office first reported a position in UnitedHealth in Q3 2014 and has held it in 31 quarters since.
- Pathstone Family Office's UnitedHealth position peaked at $221M in Q4 2022.
- 3,137 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2023.
Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.